{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:42:45Z","timestamp":1788388965367,"version":"build-2803163510"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bull Exp Biol Med"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10517-025-06459-y","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T02:19:56Z","timestamp":1756433996000},"page":"206-210","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Effect of Tryptanthrin and Its Oxime on the Blood\u2013Brain Barrier Permeability in Rats with Cerebral Infarction"],"prefix":"10.1007","volume":"179","author":[{"given":"G. A.","family":"Chernysheva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. I.","family":"Smolyakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. B.","family":"Plotnikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. I.","family":"Aliev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. A.","family":"Ulyakhina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. N.","family":"Osipenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. R.","family":"Kovrizhina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. I.","family":"Khlebnikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"6459_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.594672","volume":"11","author":"S Bernardo-Castro","year":"2020","unstructured":"1 Bernardo-Castro S, Sousa JA, et al. Pathophysiology of blood-brain barrier permeability throughout the different stages of ischemic stroke and its implication on hemorrhagic transformation and recovery. Front Neurol. 2020;11:594672. https:\/\/doi.org\/10.3389\/fneur.2020.594672","journal-title":"Front Neurol."},{"issue":"1","key":"6459_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/jnc.14626","volume":"148","author":"F Li","year":"2019","unstructured":"Li F, Yang B, Li T, et al. HSPB8 over-expression prevents disruption of blood-brain barrier by promoting autophagic flux after cerebral ischemia\/reperfusion injury. J Neurochem. 2019;148(1):97-113. https:\/\/doi.org\/10.1111\/jnc.14626","journal-title":"J Neurochem."},{"issue":"3","key":"6459_CR3","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1002\/jcp.29183","volume":"235","author":"J Zheng","year":"2020","unstructured":"Zheng J, Dai Q, Han K, et al. JNK-IN-8, a c-Jun N-terminal kinase inhibitor, improves functional recovery through suppressing neuroinflammation in ischemic stroke. J Cell Physiol. 2020;235(3):2792-9. https:\/\/doi.org\/10.1002\/jcp.29183","journal-title":"J Cell Physiol."},{"key":"6459_CR4","doi-asserted-by":"publisher","unstructured":"Wang LW, Tu YF, Huang CC, et al. JNK signaling is the shared pathway linking neuroinflammation, blood-brain barrier disruption, and oligodendroglial apoptosis in the white matter injury of the immature brain. J Neuroinflammation. 2012;9:Article 175. https:\/\/doi.org\/10.1186\/1742-2094-9-175.","DOI":"10.1186\/1742-2094-9-175"},{"issue":"3","key":"6459_CR5","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s10517-024-06186-w","volume":"177","author":"GA Chernysheva","year":"2024","unstructured":"Chernysheva GA, Smolyakova VI, Plotnikov MB, et al. Comparative evaluation of neuroprotective activity of tryptanthrin and its oxime in middle cerebral artery occlusion in rats. Bull Exp Biol Med. 2024;177(3):344-8. https:\/\/doi.org\/10.1007\/s10517-024-06186-w","journal-title":"Bull Exp Biol Med."},{"key":"6459_CR6","doi-asserted-by":"publisher","unstructured":"Lee S, Kim DC, Baek HY, et al. Anti-neuroinflammatory effects of tryptanthrin from Polygonum tinctorium Lour. in lipopolysaccharide-stimulated BV2 microglial cells. Arch Pharm Res. 2018;41(4):419-30. https:\/\/doi.org\/10.1007\/s12272-018-1020-8","DOI":"10.1007\/s12272-018-1020-8"},{"key":"6459_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fncel.2017.00018","volume":"11","author":"YW Kwon","year":"2017","unstructured":"Kwon YW, Cheon SY, Park SY, et al. Tryptanthrin suppresses the activation of the LPS-treated BV2 microglial cell line via Nrf2\/HO-1 antioxidant signaling. Front Cell Neurosci. 2017;11:18. https:\/\/doi.org\/10.3389\/fncel.2017.00018","journal-title":"Front Cell Neurosci."},{"key":"6459_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ejmech.2018.10.023","volume":"161","author":"IA Schepetkin","year":"2019","unstructured":"Schepetkin IA, Khlebnikov AI, Potapov AS, et al. Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors. Eur J Med Chem. 2019;161:179-91. https:\/\/doi.org\/10.1016\/j.ejmech.2018.10.023","journal-title":"Eur J Med Chem."},{"key":"6459_CR9","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.3389\/fphar.2020.01145","volume":"11","author":"LN Kirpotina","year":"2020","unstructured":"Kirpotina LN, Schepetkin IA, Hammaker D, et al. Therapeutic effects of tryptanthrin and tryptanthrin-6-oxime in models of rheumatoid arthritis. Front Pharmacol. 2020;11:1145. https:\/\/doi.org\/10.3389\/fphar.2020.01145","journal-title":"Front Pharmacol."},{"issue":"1","key":"6459_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1161\/01.str.20.1.84","volume":"20","author":"EZ Longa","year":"1989","unstructured":"Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20(1):84-91. https:\/\/doi.org\/10.1161\/01.str.20.1.84","journal-title":"Stroke."},{"issue":"17","key":"6459_CR11","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1016\/s0960-894x(02)00431-6","volume":"12","author":"VM Sharma","year":"2002","unstructured":"Sharma VM, Prasanna P, Seshu KV, et al. Novel indolo[2,1-b]quinazoline analogues as cytostatic agents: synthesis, biological evaluation and structure-activity relationship. Bioorg Med Chem Lett. 2002;12(17):2303-7. https:\/\/doi.org\/10.1016\/s0960-894x(02)00431-6","journal-title":"Bioorg Med Chem Lett."},{"issue":"3","key":"6459_CR12","doi-asserted-by":"publisher","first-page":"433","DOI":"10.4103\/1673-5374.293129","volume":"16","author":"H Martinez-Coria","year":"2021","unstructured":"Martinez-Coria H, Arrieta-Cruz I, Cruz ME, et al. Physiopathology of ischemic stroke and its modulation using memantine: evidence from preclinical stroke. Neural Regen Res. 2021;16(3):433-9. https:\/\/doi.org\/10.4103\/1673-5374.293129","journal-title":"Neural Regen Res."},{"issue":"1","key":"6459_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4103\/1673-5374.393104","volume":"20","author":"Y Wang","year":"2025","unstructured":"Wang Y, Yuan T, Lyu T, et al. Mechanism of inflammatory response and therapeutic effects of stem cells in ischemic stroke: current evidence and future perspectives. Neural Regen Res. 2025;20(1):67-81. https:\/\/doi.org\/10.4103\/1673-5374.393104","journal-title":"Neural Regen Res."},{"issue":"6","key":"6459_CR14","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/WCO.0000000000000248","volume":"28","author":"R Prakash","year":"2015","unstructured":"Prakash R, Carmichael ST. Blood-brain barrier breakdown and neovascularization processes after stroke and traumatic brain injury. Curr Opin Neurol. 2015;28(6):556-64. https:\/\/doi.org\/10.1097\/WCO.0000000000000248","journal-title":"Curr Opin Neurol."},{"issue":"4","key":"6459_CR15","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s13311-016-0483-x","volume":"13","author":"J Anrather","year":"2016","unstructured":"Anrather J, Iadecola C. Inflammation and stroke: an overview. Neurotherapeutics. 2016;13(4):661-70. https:\/\/doi.org\/10.1007\/s13311-016-0483-x","journal-title":"Neurotherapeutics."},{"issue":"2","key":"6459_CR16","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/jcbfm.2014.199","volume":"35","author":"M Krueger","year":"2015","unstructured":"Krueger M, Bechmann I, Immig K, et al. Blood-brain barrier breakdown involves four distinct stages of vascular damage in various models of experimental focal cerebral ischemia. J Cereb Blood Flow Metab. 2015;35(2):292-303. https:\/\/doi.org\/10.1038\/jcbfm.2014.199","journal-title":"J Cereb Blood Flow Metab."},{"issue":"2","key":"6459_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/ncrna5020035","volume":"5","author":"JA Slota","year":"2019","unstructured":"Slota JA, Booth SA. MicroRNAs in neuroinflammation: implications in disease pathogenesis, biomarker discovery and therapeutic applications. Noncoding RNA. 2019;5(2):35. https:\/\/doi.org\/10.3390\/ncrna5020035","journal-title":"Noncoding RNA."},{"issue":"2","key":"6459_CR18","doi-asserted-by":"publisher","first-page":"C135","DOI":"10.1152\/ajpcell.00136.2018","volume":"316","author":"C Yang","year":"2019","unstructured":"Yang C, Hawkins KE, Dor\u00e9 S, et al. Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke. Am J Physiol Cell Physiol. 2019;316(2):C135-53. https:\/\/doi.org\/10.1152\/ajpcell.00136.2018","journal-title":"Am J Physiol Cell Physiol."}],"container-title":["Bulletin of Experimental Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-025-06459-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10517-025-06459-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-025-06459-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:04:09Z","timestamp":1757552649000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10517-025-06459-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["6459"],"URL":"https:\/\/doi.org\/10.1007\/s10517-025-06459-y","relation":{},"ISSN":["0007-4888","1573-8221"],"issn-type":[{"value":"0007-4888","type":"print"},{"value":"1573-8221","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"7 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}